Researchers are exploring the benefits of cryotherapy, an alternative therapy where the body is exposed to freezing or near-freezing temperatures like an ice bath or cold plunge. Though evidence is ...

Key takeaways: A panel discussion highlighted promising advances in diabetes technology and medicine aimed at preventing and managing hypoglycemia. Real-world experiences illustrated the challenges ...

This article is made possible by a generous donation from our partner, Fay. With services like Fay, virtual access to registered dietitians is now flexible, personalized, and covered by insurance.

People with diabetes often receive a variety of lab tests to monitor their diabetes management and their risk of complications. Dr. Fran Kaufman breaks down the most common tests, what they measure, ...

Researchers at ATTD 2023 discussed some of the latest advancements in non-invasive glucose monitoring, including two new approaches to tackling this challenge. Many researchers and people with ...

The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean, including your options for first-line ...

For the first time, researchers are exploring the effectiveness of tirzepatide – which is currently only approved for type 2 diabetes – for people with type 1 diabetes and obesity or overweight.

New interoperability options available for Freestyle Libre Plus 2 and 3, iLet Bionic Pancreas, Dexcom G7, and Tandem t:slim X2 insulin pump systems.

Teva Pharmaceuticals has launched the first ever generic GLP-1 receptor agonist in the U.S. The launch comes just as many people with diabetes have struggled to access incretin medications like ...

While continuous glucose monitors are part of routine care for people with type 1 diabetes, there are many other people who may also benefit from real-time insight into glucose levels. Experts ...

Trying to learn how to lower morning blood sugar? Here’s why your glucose levels rise in the morning and a few things you can try to keep them in range.

The FDA is cautioning people that the diabetes medication Ozempic – commonly prescribed off-label for weight loss – may be linked to a rare but severe side effect. After multiple reports of intestinal ...